Global Biochips Market
Sizing, Segmentation, & Growth Forecast (2025-2030)
Last updated: August 2026
Report Scope: The downloadable datasheet contains market sizes in USD for the period 2025-30.
Market Breakdown: Sizes and growth rates are broken down by geography and market segment (see below for details).
1. Summary
The Global Biochips Market was valued at $14.5 bn. in 2025. During the forecast period 2025-2030, it is expected to grow at 11.5% CAGR, to an estimated market size of $25.0 bn. in 2030. A detailed breakdown by segment and geography is provided in the downloadable datasheet.
2. Market Definition
The global biochips market comprises miniaturized solid-state platforms that integrate biological recognition elements, such as DNA probes or antibodies, with microfabricated transducers. These devices, including DNA microarrays, lab-on-a-chip (LOC) systems, and protein chips, enable high-throughput, multiplexed analysis for clinical diagnostics, drug discovery, and genomic research, while excluding traditional large-scale laboratory equipment.
3. Trends & Demand Drivers
Several key trends are expected to significantly impact the Biochips Market in the period 2025-30:
- The rising demand for precision oncology is driving the adoption of biochips for multiplexed genomic profiling to guide targeted cancer therapies.
- Expansion of point-of-care (POC) testing is accelerating the development of portable, microfluidic-based diagnostic tools for rapid infectious disease detection.
- The integration of Artificial Intelligence (AI) and machine learning is enhancing the speed and accuracy of high-density microarray data interpretation.
- Increasing utilization of organ-on-chip technology provides a high-fidelity alternative to animal testing in pharmaceutical drug toxicity screening.
- Advancements in Next-Generation Sequencing (NGS) biochip architectures are enabling more sensitive single-cell and rare-molecule analysis.
- Significant venture capital investment and strategic acquisitions by major biotech firms are fueling the commercialization of proprietary chip architectures.
- High manufacturing costs and complex fabrication requirements remain primary restraints, particularly for startups and emerging market adoption.
4. Market Breakdown
The downloadable datasheet breaks market sizes and growth rates (CAGRs) down into the following geographies and segments:
Geographies
- North America
- Europe
- Asia-Pacific
- Rest of World
Segments
- Lab-on-a-Chip
- DNA Chips
- Protein Chips
- Other (Cell/Tissue Arrays)